Evidence map›Paper›PMID 37013939›Full record

ArticleCancer science2023

Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan.

Yuriko N Koyanagi, Keitaro Matsuo, Hidemi Ito, Chaochen Wang, Akiko Tamakoshi, Yumi Sugawara, Ichiro Tsuji, Ayami Ono, Shoichiro Tsugane, Norie Sawada and 10 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Risk Prediction Models for Gastric Cancer: A Scoping Review.Journal of multidisciplinary healthcare · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 1 country.

Yuriko N KoyanagiDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID https://orcid.org/0000-0002-5675-3429
Keitaro MatsuoDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID https://orcid.org/0000-0003-1761-6314
Hidemi ItoDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.ORCID https://orcid.org/0000-0002-8023-4581
Chaochen WangJapan Value, Evidence and Outcomes, Japan Drug Development and Medical Affairs Eli Lilly Japan K.K., Kobe, Japan.
Akiko TamakoshiDepartment of Public Health, Hokkaido University Faculty of Medicine, Sapporo, Japan.
Yumi SugawaraDivision of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID https://orcid.org/0000-0002-0197-6772
Ichiro TsujiDivision of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ayami OnoDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Shoichiro TsuganeDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.
Norie SawadaDivision of Cohort Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID https://orcid.org/0000-0002-9936-1476
Keiko WadaDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.ORCID https://orcid.org/0000-0002-5467-8592
Chisato NagataDepartment of Epidemiology and Preventive Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
Taro TakeuchiDepartment of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.ORCID https://orcid.org/0000-0002-9900-9608
Tetsuhisa KitamuraDepartment of Environmental Medicine and Population Sciences, Graduate School of Medicine, Osaka University, Suita, Japan.
Mai UtadaDepartment of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
Ritsu SakataDepartment of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan.
Tetsuya MizoueDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Sarah Krull AbeDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID https://orcid.org/0000-0003-3991-2739
Manami InoueDivision of Prevention, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID https://orcid.org/0000-0003-1276-2398
Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan
Aichi Cancer Center · JPGifu University · JPOsaka Gakuin University · JPRadiation Effects Research Foundation · JPTohoku University · JPEli Lilly (Japan) · JPHokkaido University · JPNational Center for Global Health and Medicine · JPNational Institute of Infectious Diseases · JP

Funding

Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer H16-3jigan-010Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer H18-3jigan-ippan-001Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer H21-3jigan-ippan-003Japan and The US government RERF Research Protocol A2-15The National Cancer Center Research and Development Fund 2021-A-16The National Cancer Center Research and Development Fund 24-A-3The National Cancer Center Research and Development Fund 27-A-4The National Cancer Center Research and Development Fund 30-A-15
6 · The paper itself

Abstract

The effect of body mass index (BMI) on esophageal and gastric carcinogenesis might be heterogeneous, depending on subtype or subsite. However, findings from prospective evaluations of BMI associated with these cancers among Asian populations have been inconsistent and limited, especially for esophageal adenocarcinoma and gastric cardia cancer. We performed a pooled analysis of 10 population-based cohort studies to examine this association in 394,247 Japanese individuals. We used Cox proportional hazards regression to estimate study-specific hazard ratios (HRs) and 95% confidence intervals (CIs), then pooled these estimates to calculate summary HRs with a random effects model. During 5,750,107 person-years of follow-up, 1569 esophageal cancer (1038 squamous cell carcinoma and 86 adenocarcinoma) and 11,095 gastric (728 cardia and 5620 noncardia) cancer incident cases were identified. An inverse association was observed between BMI and esophageal squamous cell carcinoma (HR per 5-kg/m

Indexed as

AdenocarcinomaEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaStomach NeoplasmsBody Mass IndexHumansJapanProspective StudiesRisk Factorsbody mass indexesophageal cancergastric cancerlarge-scale population-based cohort studiespooled analysis

Identifiers

PMID37013939
PMCPMC10323111
OpenAlexW4362521209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.